C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/09/2004	US20040250315 Sd1 gene involved in plants semidwarfing and utilization thereof
12/09/2004	US20040250314 Transformed Brassica CC genome comprising Brassica AA transparent seed coat gene
12/09/2004	US20040250313 Polypeptides for use in conferring herbicide, insect, nematode and stress tolerance in plants; altered yields; enhanced nutritional value; tissue engineering
12/09/2004	US20040250312 Transgenic plants and plant cells with reduced expression of invertase inhibitors
12/09/2004	US20040250311 AXMI-008, a delta-endotoxin gene and methods for its use
12/09/2004	US20040250310 Expression vector comprising nucleotide sequences coding insecticidal proteins for use in generating insect resistant plants; tissue engineering; biological pest control
12/09/2004	US20040250309 Novel compositions with chitinase activity
12/09/2004	US20040250308 Transferring heterologous nucleotide sequences into fertilized eggs prior to formation of protective layer; tissue engineering and homologous recombination
12/09/2004	US20040250307 Transgenic avian species for making human and chimeric antibodies
12/09/2004	US20040250306 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders
12/09/2004	US20040250304 Novel collagen-like protein clac, precussor thereof and genes encoding the same
12/09/2004	US20040250303 Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
12/09/2004	US20040250302 Transgenic flies expressing Abeta42-dutch
12/09/2004	US20040250301 Transgenic animals
12/09/2004	US20040250300 Expression of proteins in milk
12/09/2004	US20040250298 Methods for selecting and screening for transformants
12/09/2004	US20040249227 Biosensor and method for detecting analytes by means of time-resolved luminescene
12/09/2004	US20040249178 Biological conjugates used for drug delivery; side effect reduction
12/09/2004	US20040249146 Nucleic acid compositions conferring altered visual phenotypes
12/09/2004	US20040249143 Hagfish cathelin-associated antimicrobial peptides and genes
12/09/2004	US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss
12/09/2004	US20040249134 Factor viii c2 domain variants
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249131 Mycobacterial sulfation pathway proteins and methods of use thereof
12/09/2004	US20040249130 Aptamer-toxin molecules and methods for using same
12/09/2004	US20040249128 Disease detection polypeptides diagnosis, treatment, and prevention of cell proliferative, autoimmune/inflammatory, developmental and neurological disorders
12/09/2004	US20040249126 Chimeric antigen-specific t cell-activating polypeptides
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248976 A DNA fragment probe is used to bind specifically to a target substance; a moisturizer is used to spot the probe to be fixed on a substrate, promote omission, stabilizing the spot shape, increase detection sensitivity of a reaction chip
12/09/2004	US20040248842 Complexes for transporting nucleic acid into eukaryotic higher-cells
12/09/2004	US20040248841 Genetic engineered Dna; stability, efficiency; Rna interference
12/09/2004	US20040248840 Oligomeric compounds for the modulation of ras expression
12/09/2004	US20040248839 RNAi targeting of viruses
12/09/2004	US20040248837 Methods of treating pulmonary fibrotic disorders
12/09/2004	US20040248835 Administering by inhalation, injection or orally; Rna interference in vitro; genetic engineering
12/09/2004	US20040248834 Suppressors of cpg oligonucleotides and methods of use
12/09/2004	US20040248832 Enhancement of transfection of dna into the liver
12/09/2004	US20040248831 Oligodeoxynucleic acid modified with (thio)phosphate
12/09/2004	US20040248830 Agents that regulate apoptosis
12/09/2004	US20040248829 Gene expression in embryonic pancreas cells, adipocytes; prevent metabolic disorders; antidiabetic agents; obesity; eating disorders; neurodegenerative disorders
12/09/2004	US20040248828 Antisense modulation of interleukin 12 p35 subunit expression
12/09/2004	US20040248827 Replicative defective
12/09/2004	US20040248810 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
12/09/2004	US20040248796 VEGF-B and PDGF modulation of stem cells
12/09/2004	US20040248794 Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells
12/09/2004	US20040248791 Insect g protein-coupled receptor genes and uses thereof
12/09/2004	US20040248790 eating regulator, a sleep regulator,.an arousal regulator, a pain regulator, a stress response regulator, a spontaneous behavior regulator or an emotional behavior regulator
12/09/2004	US20040248787 fusion protein comprising a PTD (protein transduction domain) and an MITF (microphthalmia-associated transcripution factor) variant as an active ingredient with a His tag
12/09/2004	US20040248786 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/09/2004	US20040248785 mutant factor VIII has procoagulant activity; increased half-life; substituted amino acid(s) in the A2 domain
12/09/2004	US20040248780 GSSP-2, GSSP-2 cDNAs and GSSP-2 polypeptides; recombinant vector; host cell
12/09/2004	US20040248767 Modulating serum amyloid a interaction with tanis and agents useful for same
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248321 Membrane protein for use in treatment and prevention of inflammatory, circulatory, cell proliferative, metabolic and immunological disorders
12/09/2004	US20040248304 Regulatory sequences associated with nematode resistance genes for use in generation of transgenic diseases resistant plants; biological pest control
12/09/2004	US20040248303 Inducible promoter
12/09/2004	US20040248302 Brassica pyruvate dehydrogenase kinase gene
12/09/2004	US20040248301 Adeno-associated virus vectors with intravector heterologous terminal palindromic sequences
12/09/2004	US20040248300 Plasmid construct for use in transfer and expression of heterologous gene sequences for use in treatment of nervous system disorders in mammals
12/09/2004	US20040248299 RNA interference
12/09/2004	US20040248298 Methods for purification of bacterial cells and components
12/09/2004	US20040248297 Antisense modulation of phospholipase a2, group vi (ca2+independent) expression
12/09/2004	US20040248296 HIV therapeutic
12/09/2004	US20040248289 Tandem repeat markers
12/09/2004	US20040248288 Compositions and methods for efficient aav vector production
12/09/2004	US20040248280 Animal feed containing polypeptides
12/09/2004	US20040248272 Heat-labile desoxyribonuclease I variants
12/09/2004	US20040248264 Nucleotide sequence coding phosphotransferase for use in the transformation and propagation of transgenic corynebacterium; fermentation of lysine for use in preparing nutrient broths, animal feeds and cosmetics
12/09/2004	US20040248263 Using reaction mixture comprisng polyphosphate-dependent NAD+ kinase and polyphosphoric acid to generate nicotinamide adenine dinucleotide phosphate for use as diagnostic reagent for enzymatically analyzing blood and urine
12/09/2004	US20040248258 Methods for producing secreted polypeptides
12/09/2004	US20040248257 Spleen expressed cell surface protein (SPLEX) for use in treatment and prevention autoimmunity, cancer, transplant rejection and inflammation
12/09/2004	US20040248256 Secreted proteins and polynucleotides encoding them
12/09/2004	US20040248255 Leukocyte stimulating peptides
12/09/2004	US20040248254 ACPL DNA and polypeptides
12/09/2004	US20040248253 Methods and compositions for polypeptide engineering
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248250 Method for modifying enzyme and oxidoreductive variant
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248247 Helix-loop-helix (BHLH) motif and a per-rrnt-sim homology domain (pas domain) (BHLH-PAS) protein for use in identifying modulators for diagnosis, prevention and treatment of retardation and nervous system disorders
12/09/2004	US20040248246 Compositions and methods for enhancing differential expression
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248241 Compositions and methods for eliciting an immune response to Gram-negative bacterial infections
12/09/2004	US20040248240 Nucleotide sequences coding membrane protein for use in identifying modulator for treatment of pain management, epilepsy, stroke, ischemia and heart disease
12/09/2004	US20040248238 Method for increasing the solubility, expression rate and the acitivity of proteins during recombinant production
12/09/2004	US20040248236 Bacillus strain and antibiotic screening method
12/09/2004	US20040248233 Using propyl hydroxylase expression system to identify modulators which interfere with or prevent generation of hypoxic states; screening modulator for treatment and prevention of cell proliferative and thrombotic disorder
12/09/2004	US20040248231 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders
12/09/2004	US20040248224 Detection of antibodies to squalene in serum
12/09/2004	US20040248220 Using cadherin expression as diagnostic and prognostic indicator of tumor cell expression and/or progression
12/09/2004	US20040248219 Methods for diagnosing and evaluating cancer
12/09/2004	US20040248211 Hybridoma cell line comprising intracellular adhesion molecules for use in generating immunoglobulins to treatment autoimmune, skin and inflammatory disorders
12/09/2004	US20040248207 Sodium channel regulators and modulators
12/09/2004	US20040248195 Uses of a thyx polypeptide or a nucleic acid encoding such a polypeptide, in particular for screening anti-bacterial or anti-viral compounds
12/09/2004	US20040248186 Nucleic acid sequencing by Raman monitoring of uptake of precursors during molecular replication
12/09/2004	US20040248185 Nucleic acid sequencing by raman monitoring of uptake of precursors during molecular replication
12/09/2004	US20040248180 Nucleotide sequences coding modified chromgenic and/or fluorescent protein for use as diagnostic indicators in genetic engineering
12/09/2004	US20040248179 Cbg gene as a genetic marker of hypercortisolism and associated pathologies
12/09/2004	US20040248178 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
12/09/2004	US20040248177 Human hypercholesterolemia causal gene and use thereof

1 ... 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 ... 4023